Victory Capital Management Inc. Lowers Position in AVANOS MEDICAL, INC. (NYSE:AVNS)

Victory Capital Management Inc. lessened its stake in AVANOS MEDICAL, INC. (NYSE:AVNS) by 32.1% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 50,884 shares of the company’s stock after selling 24,066 shares during the quarter. Victory Capital Management Inc.’s holdings in AVANOS MEDICAL were worth $729,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. GAMMA Investing LLC lifted its stake in AVANOS MEDICAL by 2,381.6% during the 1st quarter. GAMMA Investing LLC now owns 17,024 shares of the company’s stock valued at $244,000 after acquiring an additional 16,338 shares in the last quarter. Bank of America Corp DE lifted its position in shares of AVANOS MEDICAL by 2.5% during the fourth quarter. Bank of America Corp DE now owns 63,672 shares of the company’s stock valued at $1,014,000 after purchasing an additional 1,537 shares in the last quarter. Principal Financial Group Inc. grew its position in AVANOS MEDICAL by 2.6% in the 1st quarter. Principal Financial Group Inc. now owns 244,063 shares of the company’s stock worth $3,497,000 after purchasing an additional 6,269 shares in the last quarter. Envestnet Asset Management Inc. increased its stake in AVANOS MEDICAL by 15.8% in the 4th quarter. Envestnet Asset Management Inc. now owns 128,567 shares of the company’s stock valued at $2,047,000 after buying an additional 17,504 shares during the last quarter. Finally, Vanguard Group Inc. increased its stake in AVANOS MEDICAL by 0.4% in the 4th quarter. Vanguard Group Inc. now owns 5,339,778 shares of the company’s stock valued at $85,009,000 after buying an additional 19,476 shares during the last quarter. Hedge funds and other institutional investors own 95.17% of the company’s stock.

AVANOS MEDICAL Price Performance

AVANOS MEDICAL stock opened at $11.00 on Friday. The stock has a market cap of $508.41 million, a P/E ratio of -1.31 and a beta of 1.12. The company has a quick ratio of 1.56, a current ratio of 2.57 and a debt-to-equity ratio of 0.12. The company’s 50 day moving average price is $12.11 and its two-hundred day moving average price is $13.60. AVANOS MEDICAL, INC. has a 52 week low of $10.86 and a 52 week high of $25.36.

AVANOS MEDICAL (NYSE:AVNS) last issued its quarterly earnings results on Tuesday, May 6th. The company reported $0.26 EPS for the quarter, topping analysts’ consensus estimates of $0.19 by $0.07. The business had revenue of $167.50 million for the quarter, compared to analyst estimates of $161.75 million. AVANOS MEDICAL had a positive return on equity of 6.26% and a negative net margin of 55.80%. AVANOS MEDICAL’s quarterly revenue was up .8% compared to the same quarter last year. During the same period last year, the company posted $0.22 earnings per share. On average, equities analysts predict that AVANOS MEDICAL, INC. will post 1.32 earnings per share for the current year.

AVANOS MEDICAL Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.